Improved outcomes of clinical trials for substance use disorders
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95024Q00453
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Place of performance
- Baltimore, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse is seeking research services to improve outcomes of clinical trials for substance use disorders, including stimulant and opioid use disorders. The objective is to manage and analyze harmonized datasets of these clinical trials to examine novel and clinically relevant outcome measures beyond total abstinence, with the goal of potentially improving the effect size of medications tested. Proposals will be evaluated on technical and scientific capability, personnel qualifications and experience, and price reasonableness. Quotes are due by 8:00 PM Eastern Time on August 15, 2024 and must be submitted electronically to the Contracting Officer.
This is a total small business set-aside acquisition for a firm-fixed-price purchase order with a 12-month period of performance from September 3, 2024 to September 2, 2025. The North American Industry Classification System (NAICS) code is 541690 - Other Scientific and Technical Consulting Services, and the Product Service Code (PSC) is AN21-P - Health R&D Services; Health Research And Training; Basic Research. The place of performance is Baltimore, MD, USA.
Notice text
The objective of the proposed project is to manage and analyze harmonized datasets of StUD and OUD clinical trials to examine novel and clinically relevant outcome measures. Please see the attachments for more details.
Files
| File | Type | Posted |
|---|---|---|
| RFQ_Att 3_Invoicing Instructions Without IPP 4-21-22.docx | DOCX document | |
| RFQ_75N95024Q00453.pdf | ||
| RFQ_Att 1_SOW.docx | DOCX document | |
| RFQ_Att 3_Invoicing Instructions With IPP 4-21-22.pdf | ||
| RFQ_Att 2_FAR 52.212-5.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Improved outcomes of clinical trials for substance use disorders | Award Notice | |
| This notice | Solicitation | |
| Improved outcomes of clinical trials for substance use disorders | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business | |
| Best Pharmaceuticals for Children Act Data Coordination Center | National Institute of Child Health and Human Development | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity